NJBIZ

NJ Bio is a specialized Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) headquartered in Princeton, New Jersey. The company provides high-end chemistry and bioconjugation services, with a primary focus on the development of Antibody-Drug Conjugates (ADCs) and other complex bioconjugates. NJ Bio offers comprehensive expertise in linker-payload synthesis, site-specific conjugation, and the characterization of complex biologics. They support pharmaceutical and biotechnology clients from early-stage discovery through clinical development and manufacturing. The company is recognized for its ability to handle difficult-to-make molecules and its precision in bioconjugation technologies.